Immunity to Flavobacterium Psychrophilium Antigens and Development of a Coldwater Disease (CWD) Vaccine

Award Information
Agency:
Department of Agriculture
Branch
n/a
Amount:
$296,000.00
Award Year:
2003
Program:
SBIR
Phase:
Phase II
Contract:
2003-33610-13945
Agency Tracking Number:
2003-04084
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Clear Springs Foods, Inc.
P. O. Box 712, Buhl, ID, 83316
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
Scott LaPatra
Director of R&D
(208) 543-3456
scottl@clearsprings.com
Business Contact:
John MacMillan
Vice President, Research & Environmental
(208) 543-3456
randy@clearsprings.com
Research Institution:
n/a
Abstract
NON-TECHNICAL SUMMARY: Economic impacts due to coldwater disease (CWD) have dramatically increased in recent years at public and private aquaculture facilities and CWD is the number one disese problem in the commercial rainbow trout industry in Idaho. In the United States, antibiotics available for the therapeutic treatment of fish with this disease are very limited and not expected to increase. Vaccination against this disease would provide the most benefit to aquaculturists through prevention of epizootics and a subsequent decrease in the need for antibiotic treatment. The Phase II studies are essential to provide a better understanding of the undrlying mechanism(s) involved in a protective immune response against Flavobacterium psychrophilum. This work will provide the foundation for the development and commercialization of a vaccine against CWD in Phase III.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government